ORTIN BIOTECH is a division of Ortin Laboratories Limited with an emphasis on in-house R & D, dedicated to supporting research efforts along the biopharmaceuticals and Diagnostics. Ortin’s focus is on Cancer, Diabetes ,Cardiac and Inflammatory diseases. We offer novel therapies on a platform of affordable innovation, keeping the customer need into focus and quality under constant vigil.
We provide services in the area of Process development, Process Characterisation, Analytical Research & Development, Assay development and Product Characterisation. With its world class infrastructure, Ortin biotech can do cGMP synthesis from milligram to kilogram. In addition to supplies of APIs, we undertake long-term contracts for manufacturing intermediates and development of new Active Pharmaceutical Ingredients. Diagnostics services includes development of Rapid flow kits, Assay development and Reagents.